INVA
Companies
NASDAQ
Innoviva Inc.
Health Care
$21.46
+$4.11 (+23.69%)
Price Chart
Overview
About INVA
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Market Cap
$1.0B
Volume
12.6M
Avg. Volume
15.3M
P/E Ratio
12.775511
Dividend Yield
5.28%
Employees
62.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.42
Low Correlation
Volatility
Low (0.18)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, INVA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.0B
Volume12.6M
P/E Ratio12.78
Dividend Yield5.28%
Important Dates
Next Dividend
Next Earnings
May 8, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025